Fyrnys B[au] - Search Results

Year	Number of Results
1992	1
1995	1
1996	1
1997	1
1999	1
2001	1
2005	1
2019	1
2023	0

1

Genuair^®/Pressair^® Inhaler in COPD: The Patient Perspective.

Magnussen H, Fyrnys B, Greguletz R. Magnussen H, et al. Among authors: fyrnys b. COPD. 2019 Apr;16(2):196-205. doi: 10.1080/15412555.2019.1630807. Epub 2019 Jul 2. COPD. 2019. PMID: 31264482 Review.

2

Stability and performance characteristics of a budesonide powder for inhalation with a novel dry powder inhaler device.

Fyrnys B, Stang N, Wolf-Heuss E. Fyrnys B, et al. Curr Opin Pulm Med. 2001 Apr;7 Suppl 1:S7-11. Curr Opin Pulm Med. 2001. PMID: 11385814

3

Variability of fine particle dose and lung deposition of budesonide delivered through two multidose dry powder inhalers.

Munzel U, Marschall K, Fyrnys B, Wedel M. Munzel U, et al. Among authors: fyrnys b. Curr Med Res Opin. 2005 Jun;21(6):827-33. doi: 10.1185/030079905X46241. Curr Med Res Opin. 2005. PMID: 15969882 Clinical Trial.

4

Oxidized low-density lipoprotein stimulates protein kinase C (PKC) and induces expression of PKC-isotypes via prostaglandin-H-synthase in P388D1 macrophage-like cells.

Claus R, Fyrnys B, Deigner HP, Wolf G. Claus R, et al. Among authors: fyrnys b. Biochemistry. 1996 Apr 16;35(15):4911-22. doi: 10.1021/bi952036n. Biochemistry. 1996. PMID: 8664283

5

Oxidized low density lipoprotein stimulates protein kinase C (PKC) activity and expression of PKC-isotypes via prostaglandin-H-synthase in P388D1 cells.

Fyrnys B, Claus R, Wolf G, Deigner HP. Fyrnys B, et al. Adv Exp Med Biol. 1997;407:93-8. doi: 10.1007/978-1-4899-1813-0_14. Adv Exp Med Biol. 1997. PMID: 9321937

6

Rapid synthesis of 2-desoxy-2-amino-3-phosphocholine-glycerinic-acid- alkylester, 1-alkyl-1-desoxy- and 1-O-alkyl-2-desoxy-2-amino-sn-glycero-3- phosphocholines, -3-phospho-N,N'-dimethylethanolamine and -3-phospho-Fmoc- serine-methylester.

Deigner HP, Fyrnys B. Deigner HP, et al. Among authors: fyrnys b. Chem Phys Lipids. 1992 Apr;61(2):199-208. doi: 10.1016/0009-3084(92)90013-f. Chem Phys Lipids. 1992. PMID: 1511493

7

Novel reversible, irreversible and fluorescent inhibitors of platelet-activating factor acetylhydrolase as mechanistic probes.

Deigner HP, Kinscherf R, Claus R, Fyrnys B, Blencowe C, Hermetter A. Deigner HP, et al. Among authors: fyrnys b. Atherosclerosis. 1999 May;144(1):79-90. doi: 10.1016/s0021-9150(99)00034-9. Atherosclerosis. 1999. PMID: 10381281

8

Susceptibility of phospholipids of oxidizing LDL to enzymatic hydrolysis modulates uptake by P388D1 macrophage-like cells.

Fyrnys B, Blencowe C, Deigner HP. Fyrnys B, et al. FEBS Lett. 1995 Jan 2;357(1):7-12. doi: 10.1016/0014-5793(94)01312-o. FEBS Lett. 1995. PMID: 8001682 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results